MARKET

SNCA

SNCA

Neuralstem
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.9260
-0.2240
-19.48%
After Hours: 0.9001 -0.0259 -2.80% 17:57 11/15 EST
OPEN
1.130
PREV CLOSE
1.150
HIGH
1.220
LOW
0.8961
VOLUME
435.56K
TURNOVER
--
52 WEEK HIGH
13.78
52 WEEK LOW
0.8961
MARKET CAP
2.44M
P/E (TTM)
-0.0060
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SNCA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

EPS

SNCA News

  • UCB's bimekizumab success in second late-stage psoriasis study
  • seekingalpha.1d ago
  • Seneca Biopharma reports Q3 results
  • seekingalpha.2d ago
  • The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut
  • Benzinga.11/08 13:16
  • Penny Stocks to Buy Using Technical Analysis for November 2019
  • Investopedia.10/31 21:17

More

Industry

Biotechnology & Medical Research
+1.25%
Pharmaceuticals & Medical Research
+1.34%

Hot Stocks

Name
Price
%Change

About SNCA

Seneca Biopharma, Inc., formerly Neuralstem, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for diseases of unmet medical need. It is focused on finding and acquiring new assets, sciences and technologies that provide therapies for patients. It intends to focus on developing a pipeline of biopharmaceuticals and commercializing those products.
More

Webull offers Seneca Biopharma Inc (SNCA) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.